• Western blot analysis of extracts of various cell lines, using HOXB4 Rabbit monoclonal antibody (STJ11103085) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 180s.

Anti-HOXB4 antibody (1-100) [S5MR] (STJ11103085)

SKU:
STJ11103085

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit monoclonal antibody anti-HOXB4 (1-100) is suitable for use in Western Blot research applications.
Clonality: Monoclonal
Clone ID: S5MR
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 0.05% BSA, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:1000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: HOXB4
Gene ID: 3214
Uniprot ID: HXB4_HUMAN
Immunogen Region: 1-100
Immunogen: A synthetic peptide corresponding to a sequence within amino acids 1-100 of human HOXB4 (P17483).
Immunogen Sequence: MAMSSFLINSNYVDPKFPPC EEYSQSDYLPSDHSPGYYAG GQRRESSFQPEAGFGRRAAC TVQRYAACRDPGPPPPPPPP PPPPPPPGLSPRAPAPPPAG
Function Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis.
Protein Name Homeobox Protein Hox-B4
Homeobox Protein Hox-2.6
Homeobox Protein Hox-2f
Database Links Reactome: R-HSA-5617472
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Homeobox Protein Hox-B4 antibody
Anti-Homeobox Protein Hox-2.6 antibody
Anti-Homeobox Protein Hox-2f antibody
Anti-HOXB4 antibody
Anti-HOX2F antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance